Hind-limb paraparesis in a rat model for neurolathyrism associated with apoptosis and an impaired vascular endothelial growth factor system in the spinal cord

Journal of Comparative Neurology

Volumn 518, Issue 6, 2010, Pages 928-942

  Kusama Eguchi, Kuniko ^a   Yamazaki, Yoshiko ^a   Ueda, Tadashi ^b   Suda, Atsuhiro ^a   Hirayama, Yukari ^a   Ikegami, Fumio ^c   Watanabe, Kazuko ^a   May, Mike ^d   Lambein, Fernand ^d   Kusama, Tadashi ^a  

^a NIHON UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Animal models; BOAA; Degeneration; Hemorrhage; L ODAP; Motor neuron; Paraparesis; Spinal cord; VEGF receptor 2

Indexed keywords

3 OXALYLAMINOALANINE; EXCITOTOXIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLEEDING; CONTROLLED STUDY; FEMALE; HINDLIMB; HISTOCHEMISTRY; INCIDENCE; LATHYRISM; LUMBAR SPINAL CORD; MALE; MOTONEURON; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PARAPLEGIA; PARENCHYMA; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD INJURY; WESTERN BLOTTING;

AMINO ACIDS, DIAMINO; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; HEMORRHAGE; HINDLIMB; LATHYRISM; MALE; MATERNAL DEPRIVATION; MODELS, NEUROLOGICAL; MOTOR NEURONS; PARAPARESIS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD DISEASES; STRESS, PSYCHOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77949342146     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.22257     Document Type: Article

References (50)

1. Abraham IM, Harkany T, Horvath KM, Luiten PG. 2001. Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection? J Neuroendocrinol 13:749-760.
2. Boer K, Troost D, Spliet WGM, van Rijen PC, Gorter JA, Aronica E. 2008. Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptor 1 and 2 in focal cortical dysplasia type IIB. Acta Neuropathol 115:683-696.
3. Carmeliet P. 2003. Angiogenesis in health and disease. Nat Med 9:653-660.
4. Carriedo SG, Yin HZ, Weiss JH. 1996. Motor neurons are selectively vulnerable to AMPA/kainite receptor-mediated injury in vitro. J Neurosci 16:4069-4079.
5. Choi J-S, Kim H-Y, Cha J-H, Choi J-Y, Park SI, Jeong CH, Jeun S-S, Lee M-Y. 2007. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. J Histochem Cytochem 55:821-830.
6. Déry M-A C, Michaud MD, Richard DE. 2005. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 37:535-540.
7. Dugan LL, Choi DW. 1994. Excitotoxicity, free radicals, and cell membrane changes. Ann Neurol 35(Suppl):S17-S21.
8. Filiminoff IN. 1926. Zur pathologisch-anatomischen Charakteristik des Lathyrismus. Z Gesamte Neurol Psychiatr 105:76-92.
9. Forsythe JA, Jiang B-H, Iyer NV, Agani F, Leung SW, Koods RD, Semenza GL. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
10. Getahun H, Mekonnen A, Teklehaimanot R, Lambein F. 1999. Epidemic of neurolathyrism in Ethiopia. Lancet 354:306-307.
11. Getahun H, Lambein F, Vanhoorne M, Van der Stuvft P. 2001. Pattern and associated factors of the neurolathyrism epidemic in Ethiopia. Trop Med Int Health 7:118-124.
12. Grant G, Koerber HR. 2004. Spinal cord cytoarchitecture. In: Paxinos G, editor. The rat nervous system, 3rd ed. Elsevier: Academic Press. p 121-128.
13. Guillery RW. 2002. On counting and counting errors. J Comp Neurol 447:1-7.
14. Himwich WA, Pertesen JC, Allen ML. 1957. Hematoencephalic exchange as a function of age. Neurology 7:706-710.
15. Hirano A, Llena JF, Streifler M., Cohn DF. 1976. Anterior horn cell changes in a case of neurolathyrism. Acta Neuropathol 35: 277-283.
16. Holmes K, Roberts OL1, Thomas AM, Cross MJ. 2007. Vascular endothelial growth factor receptor-2: structure, function, intracellular signaling and therapeutic inhibition. Cell Signal 19: 2003-2012.
17. Hortnagl H, Berger ML, Havelec L, Hornykiewicz O. 1993. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A). J Neurosci 13:2939-2945.
18. Horvath KM, Harkany T, Mulder J, Koolhaas JM, Luiten PG, Meerlo P. 2004. Neonatal handling increases sensitivity to acute neurodegeneration in adult rats. J Neurobiol 60: 463-472.
19. Hugon J, Ludolph AC, Spencer PS, Gimenez Roldan S, Dumas JL. 1993. Studies of the etiology and pathogenesis of motor neuron diseases. III. Magnetic cortical stimulation in patients with lathyrism. Acta Neurol Scand 88:412-416.
20. Ke Q, Costa M. 2006. Hypoxia-inducible factor 1 (HIF-1). Mol Pharmacol 70:1469-1480.
21. Kessler A. 1947. Lathyrisms. Monatschrift Physicharie Neurol 113:41-54.
22. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nunez G, Peter ME, Tschopp J, Yuan J, Pinacentini M, Zhivotovsky B, Melino G, Nomenclature Committee on Cell Death. 2009. Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ 16:3-11.
23. Kusama-Eguchi K, Ikegami F, Kusama T, Suda A, Ogawa Y, Igarashi K, Watanabe K. 2005. A rat model of neurolathyrism: repeated injection of L-β-ODAP induces the paraparesis of the hind legs. Amino Acids 28:139-143.
24. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wvns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. 2003. VEGF is a modifier of amyotrophic lateral sclerosis in mice and human and protects motoneurons against ischemic death. Nat Genet 34:383-394.
25. Liebermann AR. 1971. The axon reaction: a review on the principal features of perykaryal responses to axonal injury. Int Rev Neurobiol 14:49-124.
26. Ludolph AC, Spencer PS. 1996. Toxic models of upper motor neuron disease. J Neurol Sci 139(Suppl):53-59.
27. Martin LJ. 2001. Neuronal cell death in nervous system development, disease, and injury [review]. Int J Mol Med 7:455-478.
28. Moser KV, Humpel C. 2005. Vascular endothelial growth factor conteracts NMDA-induced cell death of adult cholinergic neurons in rat basal nucleus of Maynert. Brain Res Bull 65:125-131.
29. O'Brien JT, Ames D, Schweitzer I, Mastwyk M, Colman P. 1996. Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Psychol Med 26:7-14.
30. Olney JW, Rhee V, Ho OL. 1974. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 77:507-512.
31. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D, Carmeliet P. 2001. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28:131-138.
32. Oyar EÖ, Kardeş Ö, Kormaz A, Ö meroǧlu S. 2008. Effects of vascular endothelial growth factor on ischemic spinal cord injury caused by aortic cross-clamping in rabbits. J Surg Res 148:100-108.
33. Poesen K, Lambrechts D, Van Damme P, Dhondt J, Bender F, Frank N, Bogaert E, Claes B, Heylen L, Verheyen A, Raes K, Tjwa M, Eriksson U, Shibuya M, Nuydens R, Van Den Bosch L, Meert T, D'Hooge R, Sendtner M, Robberecht W, Carmeliet P. 2008. Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. J Neurosci 28:10451-10459.
34. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. 1995. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152: 1372-1376.
35. Ravindranath V. 2002. Neurolathyrism: mitochondrial dysfunction in excitotoxicity mediated by L-β-oxyal aminoalanine. Neurochem Int 20:505-509.
36. Risau W, Wolburg H. 1990. Development of the bood-brain barrier. Trends Neurosci 70:174-178.
37. Ross SM, Seelig M, Spencer PS. 1987. Specific antagonism of excitotoxic action of "uncommon" amino acids assayed in organotypic mouse cortical cultures. Brain Res 425:120-127.
38. Ross SM, Roy DN, Spencer PS. 1989. Beta-N-oxalylamino-Lalanine action on glutamate receptors. J Neurochem 53:710-715.
39. Shibuya M, Claesson-Welsh L. 2006. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphagiogenesis. Exp Cell Res 312:549-560.
40. Spencer P. 1994. Lathyrism. In: Vinken BG, editor. Handbook of clinical neurology 65. Intoxication of the nervous system, part II. Amsterdam: Elsevier. p 1-20.
41. Storkebaum E, Carmeliet P. 2004. VEGF: a critical player in neurodegeneration. J Clin Invest 113:14-18.
42. Striefler M, Cohn DF, Hirano A, Schujman E. 1977. The central nervous system in a case of neurolathyrism. Neurology 27: 1176-1178.
43. Tizabi Y, Gilad VH, Gilad GM. 1989. Effects of chronic stressors or corticosterone treatment on the septohippocampal cholinergic system of the rat. Neurosci Lett 105:177-182.
44. Trolli G. 1938. Paraplégie spastique épidémique, "konzo": des indigènes du Kwango. In: Trolli G, editor. Résumé des observations réunies, au Kwango, au sujet de deux affections d'origine indéterminée. Brussels: Fonds Reine Elisabeth. p 1-36.
45. Tshala-Katumbay DD, Spencer PS. 2007. Toxic disorders of the upper motor neuron system. In: Eisen AA, Shaw PJ, editors. Handbook of clinical neurology 80. Motor neuron disorders and related diseases. Amsterdam: Elsevier. p 353-372
46. Urca G, Urca R. 1990. Neurotoxic effects of excitatory amino acids in the mouse spinal cord: quisqualate and kainate but not N-methyl-D-aspartate induce permanent neural damage. Brain Res 529:7-15.
47. Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, Jin K. 2007. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci 27:304-307.
48. Weiss JH, Weiss JK, Choi DW. 1989. Neurotoxicity of β-N- methylamino-L-alanine (BMAA) and β-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res 497: 64-71.
49. Whalley K, O'Neill P, Ferretti P. 2006. Changes in response to spinal cord injury with development: vascularization, hemorrhage and apoptosis. Neuroscience 137:821-832.
50. Zacchigna, S, Lambrechts, D, Carmeliet, P. 2008. Neurovascular sigmalling defects in neurodegeneration. Nat Rev 9:169-181.